Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

ARS scientists design GILZ-based peptides for use in cancer, inflammation, etc.

Aug. 6, 2003

New antitumor agents in Kyowa Hakko development pipeline

Aug. 6, 2003

Fulvestrant at least as effective as anastrozole in advanced breast cancer

Aug. 6, 2003

MorphoSys and Schering AG collaboration yields positive animal data

Aug. 6, 2003

Maxim discusses discovery and development of apoptosis inducers at cancer meeting

Aug. 5, 2003

Small-molecule Bcl-2 inhibitor with apoptosis-inducing effects in cancer cells

Aug. 5, 2003

Bexxar launched in U.S.

Aug. 5, 2003

Additional mechanism of action for IGN-311: inhibition of growth factor signaling

Aug. 4, 2003

AVE-8062A: a tumor vasculature targeting agent with promising antitumor activity

Aug. 4, 2003

New nuclear hormone receptor modulators synthesized at BMS

Aug. 4, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 6, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...